IN CELLULO IDENTIFICATION OR VALIDATION OF THERAPEUTIC TARGETS IN MYELOID LEUKEMIA USING CLICK CHEMISTRY TECHNOLOGY TO DEVELOP NEW DIAGNOSTIC METHODS OR TARGETED THERAPIES
- Preclinical development
- AML
- MDS
- CMML
- Targeted therapy
- Immunotherapy
- Chemotherapy
- Preclinical research (TRL 4-5)
Identification or validation of therapeutic targets in cellulo using click chemistry technology, to develop new diagnostic methods or targeted therapies.
The Click chemistry technology, which consists in precipitating a molecule with its target after their interaction in cellulo, offers numerous opportunities in biological and medical research. Applied in the field of hematological malignancies, it is used to identify protein targets in their cellular environment.
Description
Scope of research activities
Preclinical research to study protein targets in leukemia cells.
- Demonstration of mechanism of action
Conduct of studies
Steps:
- Analysis of study strategy
- Study design and feasibility
- Drafting of study plans
- Organization, implementation and conduct of studies
- Analysis and communication of results
Research infrastructure
Experimental and analytical platforms:
- Click-chemistry in cellulo
- Western blot (1D, 2D)
- Mass spectrometry
Models: (human or murine)
- Primary cells
- Tumor cells
- Cell lines
Technical personnel:
- 1 engineer
Specifications
The platform
Identification of therapeutic targets in cellulo using click chemistry technology.
The studies
Study steps:
- In cellulo click chemistry
- Western blot (1D, 2D)
- Mass spectrometry
Identification and validation of therapeutic targets:
- Identification of targets of a compound under therapeutic development
- Validation of targets of a compound already clinically validated
Terms
OPALE entity
C3M (UMR-1065)
Contact
Other offers
PLATFORM FOR SCREENING MOLECULES ABLE OF REPROGRAMMING PRIMARY HUMAN MACROPHAGES (AML/Myelofibrosis/MDS/CMML)
PLATFORM FOR THE ISOLATION OF ORGANELLES IN LEUKEMIA CELLS TO ASSESS FUNCTIONAL MODULATIONS LINKED TO PATHOLOGY OR CHEMOTHERAPEUTIC TREATMENT (AML/MDS/CMML)
CHARACTERIZATION OF CELL DEATH IN LEUKEMIA CELLS TO ASSESS THE EFFICACY OF THERAPEUTIC SOLUTIONS IN THE TREATMENT OF MYELOID LEUKEMIA (AML/MDS/CMML)